Seres Therapeutics (MCRB) Tops Q3 EPS by 94c

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.94. Revenue for the quarter came in at $350 thousand.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield
• A.O. Smith executive chairman to retire, CEO to assume chairman role